COVID-19 Vaccine Myocarditis∗ : Cautious Reassurance in an Era of Dynamic Uncertainty | Journal of the American College of Cardiology
Myocarditis mortality with and without COVID-19: insights from a national registry | Clinical Research in Cardiology
Reporting of immune checkpoint inhibitor-associated myocarditis - The Lancet
Frontiers | Global, Regional, and National Burden of Myocarditis and Cardiomyopathy, 1990–2017
Lack of evidence of significant homology of SARS-CoV-2 spike sequences to myocarditis-associated antigens - eBioMedicine
Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021 | MMWR
Trends in the Incidence of In-Hospital Mortality, Cardiogenic Shock, and Utilization of Mechanical Circulatory Support Devices in Myocarditis (Analysis of National Inpatient Sample Data, 2005–2014) - Journal of Cardiac Failure
Abstract 11463: Epidemiological Trends and Outcomes of Acute Myocarditis in the National Health Service of England | Circulation
COVID‐19 vaccine induced myocarditis in young males: A systematic review - Knudsen - 2023 - European Journal of Clinical Investigation - Wiley Online Library
Trends in the Incidence of In-Hospital Mortality, Cardiogenic Shock, and Utilization of Mechanical Circulatory Support Devices in Myocarditis (Analysis of National Inpatient Sample Data, 2005–2014) - ScienceDirect
SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study | The BMJ
Prognosis of Myocarditis Developing After mRNA COVID-19 Vaccination Compared With Viral Myocarditis | Journal of the American College of Cardiology
French study on cardiovascular disease incidence during COVID pandemic and vaccination campaign
Trends in myocarditis incidence, complications and mortality in Sweden from 2000 to 2014 | Scientific Reports
Role of electrocardiograms in assessment of severity and analysis of the characteristics of ST elevation in acute myocarditis: A two‑centre study
CDC - An MMWR report finds that patients with COVID-19 had almost 16 times the risk for myocarditis, or inflammation of part of the heart muscle, compared with patients who did not
The effects of gender and age on occurrence of clinically suspected myocarditis in adulthood | Heart
Increased risk of myocarditis and pericarditis and reduced likelihood of severe clinical outcomes associated with COVID-19 vaccination: a cohort study in Lombardy, Italy | BMC Infectious Diseases | Full Text
JCM | Free Full-Text | Occurrence, Trends, Management and Outcomes of Patients Hospitalized with Clinically Suspected Myocarditis—Ten-Year Perspectives from the MYO-PL Nationwide Database
Myocarditis mortality with and without COVID-19: insights from a national registry | Clinical Research in Cardiology
Long-Term Outcome of Fulminant Myocarditis as Compared with Acute (Nonfulminant) Myocarditis | NEJM
Global, regional, and national burdens of myocarditis, 1990–2019: systematic analysis from GBD 2019 | BMC Public Health | Full Text
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization | NEJM
CDC says there's likely link between rare heart inflammation in young people after Covid shot
